Nicht aus der Schweiz? Besuchen Sie lehmanns.de
New Drug Approval Process -

New Drug Approval Process

Accelerating Global Registrations

Richard A. Guarino (Herausgeber)

Buch | Hardcover
668 Seiten
2004 | 4th New edition
Crc Press Inc (Verlag)
978-0-8247-5041-1 (ISBN)
CHF 229,95 inkl. MwSt
zur Neuauflage
  • Titel erscheint in neuer Auflage
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage
Clarifying how to develop and market new drugs efficiently and economically for global markets, this text covers the emphasis on over-the-counter drugs in the long-range plans of many companies and discusses licence applications review boards.
Offering expert guidance on the clinical, regulatory, and statistical processes involved in the development of new pharmaceutical product applications for drugs, biologicals, and medical devices, the Fourth Edition details the specific regulations, guidelines, and procedures that will advance and ensure approval of United States and global new product applications. It communicates and integrates a new approach to the world of pharmaceutical personnel on all aspects of new product development and alerts readers to clinical and regulatory tasks that require immediate attention and long-term follow-up in order to comply with the international acceptance of new product approvals.

PARTIAL CONTENTS Regulatory Practices and Procedures of New Drug, Biologics and Device Development New Product Development Teams Duane B. Lakings Nonclinical Drug Development: Pharmacology, Drug Metabolism, and Toxicology Duane B. Lakings The Investigational New Drug Application (IND) and the Investigator's Brochure (IB) William M. Troetel Clinical Research Development Clinical Research Protocols Richard A. Guarino Adverse Experiences, Adverse Reactions and Interactions of Drugs Richard A. Guarino Statistical and Data Management Collaboration in Clinical Research Mark Bradshaw and Lawrence A. Meinert Specific Aspects in the Process of New Product Submissions Chemistry, Manufacturing and Control (CMC) Requirements of the NDA and ANDA Evan Siegel Data Presentation for FDA Submissions: Text and Tabular Exposition Patricia Blaine Preparing for FDA Inspections: Manufacturing Sites Timothy Urschel Global Applications of Good Clinical Practices (GCPs) Obligations of the Investigator, Sponsor and Monitor Richard A. Guarino Institutional Review Board (IRB)/Independent Ethics Committee (IEC) and Informed Consent (IC): Protecting Subjects throughout the Clinical Research Process Rochelle L. Goodson Quality Assurance Earl W. Hulihan

Erscheint lt. Verlag 21.5.2004
Reihe/Serie Drugs and the Pharmaceutical Sciences
Verlagsort Bosa Roca
Sprache englisch
Maße 152 x 229 mm
Gewicht 975 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie
Technik
ISBN-10 0-8247-5041-1 / 0824750411
ISBN-13 978-0-8247-5041-1 / 9780824750411
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich